✦ LIBER ✦

Citicoline is not protective in experimental models of Huntington's disease

✍ Scribed by Stéphane Mievis; Marc Levivier; Gilbert Vassart; Jacques Brotchi; Catherine Ledent; David Blum

Book ID: 116781018
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 412 KB
Volume: 28
Category: Article
ISSN: 0197-4580
DOI: 10.1016/j.neurobiolaging.2006.09.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experimental models of Huntington's dise

Experimental models of Huntington's disease

✍ Jeremy M. Van Raamsdonk; Michael R. Hayden; Blair R. Leavitt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Minocycline is protective in a mouse mod

Minocycline is protective in a mouse model of Huntington's disease

✍ Steven Hersch; Klaus Fink; Jean Paul Vonsattel; Robert M. Friedlander 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Experimental therapeutics in transgenic

Experimental therapeutics in transgenic mouse models of Huntington's disease

✍ Beal, M. Flint; Ferrante, Robert J. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 234 KB

Minocycline is not beneficial in a pheno

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease

✍ Elsa Diguet; Richard Rouland; François Tison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Neurturin protects striatal projection n

Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington’s disease

✍ E Pérez-Navarro; P Åkerud; S Marco; J.M Canals; E Tolosa; E Arenas; J Alberch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 314 KB

Neuroprotective effects of phytocannabin

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

✍ Onintza Sagredo; M. Ruth Pazos; Valentina Satta; José A. Ramos; Roger G. Pertwee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

We studied whether combinations of botanical extracts enriched in either D 9 -tetrahydrocannabinol (D 9 -THC) or cannabidiol (CBD), which are the main constituents of the cannabis-based medicine Sativex, provide neuroprotection in rat models of Huntington's disease (HD). We used rats intoxicated wit